Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009

NEXT STORY
Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery
PREV STORY
Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

COVID-19 Drug Associated APIs Global Market Report 2021: COVID-19 Growth And Change To 2030

author_avatar
NASDAQ Market News

Lantern Pharma Expands and Strengthens Board of Directors with Healthcare and Pharma Industry Veterans Franklyn Prendergast, MD, Ph.D. and Vijay Chandru, Ph.D.

author_avatar
NASDAQ Market News

Orion Biotechnology Canada Acquires K2Biomedical

OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of ...

author_avatar
NASDAQ Market News